Search Result "First-line therapy"
Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1640-1650
Author(s): F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi, S. Barni
Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension
Journal: Current Drug Metabolism
Volume: 14 Issue: 2 Year: 2013 Page: 265-269
Author(s): Serap Gur,Philip J. Kadowitz,Ahmet Gokce,Suresh C. Sikka,Utku Lokman,Wayne J.G. Hellstrom
Metformin: Is it Still the First Line in Type 2 Diabetes Management Algorithm?
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1061-1067
Author(s): Maria Grammatiki,Rebecca Sagar,Ramzi A. Ajjan
Oseltamivir: A First Line Defense Against Swine Flu
Journal: Medicinal Chemistry
Volume: 6 Issue: 4 Year: 2010 Page: 247-251
Author(s): Ritesh Agrawal, Prarthana V. Rewatkar, Ganesh R. Kokil, Arunima Verma, Atin Kalra
Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 5 Year: 2007 Page: 511-519
Author(s): S. Rekhraj, J. Kinross, S. Prabhudesai, A. Darzi, P. Ziprin
Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?
Journal: Current Hypertension Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 15-20
Author(s): Michel Burnier, Roberto Bullani, Bruno Vogt
Anti-VEGF and Anti-EGFR Monoclonal Antibodies in the First-line Therapy for Metastatic Colorectal Cancer - A Meta-Analysis
Journal: Current Cancer Therapy Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 282-289
Author(s): Zheng Zhou, William V. Walsh, Venu G. Bathini, Bilal Piperdi
The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 20 Year: 2012 Page: 3337-3352
Author(s): A. Sgambato,F. Casaluce,P. Maione,A. Rossi,E. Rossi,A. Napolitano,G. Palazzolo,M. A. Bareschino,C. Schettino,P. C. Sacco,F. Ciadiello,C. Gridelli
Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer
Journal: Reviews on Recent Clinical Trials
Volume: 13 Issue: 2 Year: 2018 Page: 139-149
Author(s): Matthew Snyder,Sal Bottiglieri,Khaldoun Almhanna
The Emerging Role of Histology in the Choice of First-Line Treatment of Advanced Non-Small Cell Lung Cancer: Implication in the Clinical Decision-Making
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1030-1038
Author(s): A. Rossi, P. Maione, M. A. Bareschino, C. Schettino, P. C. Sacco, M. L. Ferrara, V. Castaldo, C. Gridelli